首頁 > 市場調查報告書 > 製藥

動物用醫藥

市場調查報告書

商品編碼

1782642

全球伴侶動物藥物市場研究報告 - 產業分析、規模、佔有率、成長、趨勢及 2025 年至 2033 年預測

Global Companion Animal Medicine Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

出版日期: 2025年08月01日 | 出版商:

Value Market Research | 英文 161 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球伴侶動物藥物市場規模預計將從 2024 年的 191.2 億美元成長到 2033 年的 338.4 億美元，在 2026 年至 2033 年的預測期內，年複合成長率(CAGR) 將達到 6.55%。

伴侶動物藥品市場正經歷顯著成長，這得益於寵物擁有量的不斷成長以及人們對動物健康和保健意識的不斷提升。隨著越來越多的家庭開始接納寵物，對獸醫服務和產品的需求也隨之激增。寵物主人在尋求預防性護理方面也變得更加積極主動，這推動了疫苗、診斷和治療藥物市場的成長。這一趨勢在寵物擁有率較高的地區尤其明顯，因為這些地區的消費者願意為寵物的健康和福祉投資。隨著市場的不斷發展，獸醫技術和技術的創新有望提升伴侶動物的照護品質。

此外，寵物人性化趨勢日益成長，也顯著影響伴侶動物醫療市場。隨著寵物日益被視為家庭成員，主人也開始尋求與人類醫療保健標準相符的高品質醫療服務。這種轉變推動了對先進治療的需求，包括針對伴侶動物獨特需求的專科手術、牙科護理和營養補充劑。此外，遠距醫療在獸醫護理領域的興起，使寵物主人更容易獲得專業的建議和服務，從而進一步擴大了市場。隨著人們對寵物健康和保健的關注度不斷提高，伴侶動物醫療市場預計將蓬勃發展，以滿足寵物主人不斷變化的需求。

此外，研發領域的進步也促進了伴侶動物藥品市場的發展。新型藥物、生物製劑和診斷工具的出現，提高了診斷和治療寵物各種疾病的能力。隨著獸醫專業人員獲得更有效的治療方案，伴侶動物的整體護理品質有望得到提升。此外，獸醫專業人員與寵物產品製造商之間日益增多的合作，也促進了市場創新，從而催生出新的有效解決方案。隨著伴侶動物藥品市場的不斷發展，在對高品質獸醫護理日益成長的需求的推動下，該市場有望持續成長。

我們的報告經過精心設計，旨在為客戶提供關於各個行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵部分，以確保客戶全面了解市場格局：

市場概覽：市場的詳細介紹，包括定義、分類和行業現狀概述。

市場動態：深入分析影響市場成長的關鍵促進因素、限制因素、機會與挑戰。本部分探討技術進步、監管變化和新興趨勢等因素。

細分分析：根據產品類型、應用、最終用戶和地理位置等標準，將市場細分為不同的細分市場。此分析重點在於突出每個細分市場的表現和潛力。

競爭格局：對主要市場參與者的全面評估，包括其市場佔有率、產品組合、策略舉措和財務表現。本部分深入分析了競爭態勢以及領先公司採用的關鍵策略。

市場預測：根據歷史資料和當前市場狀況，對特定時期的市場規模和成長趨勢進行預測。這包括定量分析和圖形表示，以說明未來的市場發展軌跡。

區域分析：評估不同地理區域的市場表現，確定關鍵市場和區域趨勢。這有助於了解區域市場動態和機會。

新興趨勢與機會：識別當前及新興市場趨勢、技術創新以及潛在投資領域。本部分將深入探討未來市場發展與成長前景。

簡介 - 市場動態
市場促進因素
市場限制
機會
產業趨勢
波特五力分析
市場吸引力分析
- 按適應症分析市場吸引力
- 按給藥途徑進行的市場吸引力分析
- 依動物類型分析市場吸引力
- 按配銷通路分析市場吸引力
- 市場吸引力分析：按地區

第4章：價值鏈分析

價值鏈分析
原料分析
- 原料清單
- 原料製造商清單
- 主要原物料價格走勢
潛在買家名單
行銷管道
- 直效行銷
- 間接行銷
- 行銷通路發展趨勢

第5章：全球伴侶動物藥物市場分析：按適應症

按適應症概述
依適應症分析歷史和預測數據
傳染病
皮膚病（皮膚病）
疼痛
骨科疾病
行為障礙
其他（牙科、心臟、懷孕、癌症）

第6章：全球伴侶動物藥物市場分析：依給藥途徑

依給藥途徑概述
按給藥途徑進行的歷史和預測數據分析
口服
注射劑
外用

第7章：全球伴侶動物藥物市場分析：依動物類型

依動物類型概述
按動物類型進行的歷史和預測數據分析
狗
貓
馬匹
其他伴侶動物

第 8 章：全球伴侶動物藥物市場分析：按分銷管道

按配銷通路概覽
按配銷通路進行的歷史和預測資料分析
獸醫院
獸醫診所
零售藥局

第9章：全球伴侶動物藥物市場分析：按地區

區域展望
介紹
北美銷售分析
- 概述、歷史和預測數據銷售分析
- 北美各細分市場銷售分析
- 北美各國銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概述、歷史和預測數據銷售分析
- 歐洲各細分市場銷售分析
- 歐洲各國銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概述、歷史和預測數據銷售分析
- 亞太地區分部銷售分析
- 亞太地區國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概述、歷史和預測數據銷售分析
- 拉丁美洲各細分市場銷售分析
- 拉丁美洲各國銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概述、歷史和預測數據銷售分析
- 中東和非洲分部銷售分析
- 中東和非洲國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東和非洲其他地區銷售分析

第10章：伴侶動物藥品公司的競爭格局

伴侶動物藥物市場競爭
夥伴關係/合作/協議
併購
新產品發布
其他發展

第 11 章：公司簡介

頂級公司市佔率分析
市場集中度
Zoetis

公司概況
公司收入
產品
最新動態

Merck Animal Health

公司概況
公司收入
產品
最新動態

Boehringer Ingelheim Animal Health

公司概況
公司收入
產品
最新動態

Elanco Animal Health

公司概況
公司收入
產品
最新動態

Ceva SantA(C) Animale

公司概況
公司收入
產品
最新動態

Virbac

公司概況
公司收入
產品
最新動態

Dechra Pharmaceuticals

公司概況
公司收入
產品
最新動態

Vetoquinol

公司概況
公司收入
產品
最新動態

Neogen Corporation

公司概況
公司收入
產品
最新動態

Orion Group

公司概況
公司收入
產品
最新動態

Norbrook Holdings

公司概況
公司收入
產品
最新動態

Chanelle Pharma

公司概況
公司收入
產品
最新動態

HIPRA

公司概況
公司收入
產品
最新動態

Kyoritsu Seiyaku

公司概況
公司收入
產品
最新動態

BiogA(C)NA(C)Sis BagA3

公司概況
公司收入
產品
最新動態

注意 - 在公司簡介中，財務細節和最新發展取決於可用性，對於私人公司，可能不予涵蓋

簡介目錄圖表

Product Code: VMR112110630

Global Companion Animal Medicine Market size is anticipated to grow from USD 19.12 Billion in 2024 to USD 33.84 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 6.55% during the forecast period of 2026 to 2033.

The companion animal medicine market is experiencing significant growth, driven by the increasing pet ownership and the rising awareness of animal health and wellness. As more households welcome pets into their lives, the demand for veterinary services and products is surging. Pet owners are becoming more proactive in seeking preventive care, leading to a growing market for vaccines, diagnostics, and therapeutic treatments. This trend is particularly pronounced in regions with high pet ownership rates, where consumers are willing to invest in the health and well-being of their animals. As the market continues to evolve, innovations in veterinary medicine and technology are expected to enhance the quality of care available for companion animals.

Moreover, the growing trend of pet humanization is significantly influencing the companion animal medicine market. As pets are increasingly viewed as family members, owners are seeking high-quality medical care that mirrors human healthcare standards. This shift is driving demand for advanced treatments, including specialized surgeries, dental care, and nutritional supplements tailored to the unique needs of companion animals. Additionally, the rise of telemedicine in veterinary care is making it easier for pet owners to access professional advice and services, further expanding the market. As the focus on pet health and wellness continues to grow, the companion animal medicine market is expected to thrive, catering to the evolving needs of pet owners.

Furthermore, advancements in research and development are enhancing the companion animal medicine market. The emergence of new pharmaceuticals, biologics, and diagnostic tools is improving the ability to diagnose and treat various conditions in pets. As veterinary professionals gain access to more effective treatment options, the overall quality of care for companion animals is expected to improve. Additionally, the increasing collaboration between veterinary professionals and pet product manufacturers is fostering innovation in the market, leading to the development of new and effective solutions. As the companion animal medicine market continues to evolve, it is likely to witness sustained growth, driven by the increasing demand for high-quality veterinary care.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Indication

Infectious Diseases
Dermatologic Diseases (Skin Diseases)
Pain
Orthopedic Diseases
Behavioral Disorders
Others (Dental, Cardio, Pregnancy, Cancer)

By Route of Administration

Oral
Injectable
Topical

By Animal Type

Dogs
Cats
Horses
Other Companion Animals

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. COMPANION ANIMAL MEDICINE INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Indication
- 3.7.2 Market Attractiveness Analysis By Route of Administration
- 3.7.3 Market Attractiveness Analysis By Animal Type
- 3.7.4 Market Attractiveness Analysis By Distribution Channel
- 3.7.5 Market Attractiveness Analysis By Regions

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL COMPANION ANIMAL MEDICINE MARKET ANALYSIS BY INDICATION

5.1. Overview By Indication
5.2. Historical and Forecast Data Analysis By Indication
5.3. Infectious Diseases Historic and Forecast Sales By Regions
5.4. Dermatologic Diseases (Skin Diseases) Historic and Forecast Sales By Regions
5.5. Pain Historic and Forecast Sales By Regions
5.6. Orthopedic Diseases Historic and Forecast Sales By Regions
5.7. Behavioral Disorders Historic and Forecast Sales By Regions
5.8. Others (Dental, Cardio, Pregnancy, Cancer) Historic and Forecast Sales By Regions

6. GLOBAL COMPANION ANIMAL MEDICINE MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

6.1. Overview By Route of Administration
6.2. Historical and Forecast Data Analysis By Route of Administration
6.3. Oral Historic and Forecast Sales By Regions
6.4. Injectable Historic and Forecast Sales By Regions
6.5. Topical Historic and Forecast Sales By Regions

7. GLOBAL COMPANION ANIMAL MEDICINE MARKET ANALYSIS BY ANIMAL TYPE

7.1. Overview By Animal Type
7.2. Historical and Forecast Data Analysis By Animal Type
7.3. Dogs Historic and Forecast Sales By Regions
7.4. Cats Historic and Forecast Sales By Regions
7.5. Horses Historic and Forecast Sales By Regions
7.6. Other Companion Animals Historic and Forecast Sales By Regions

8. GLOBAL COMPANION ANIMAL MEDICINE MARKET ANALYSIS BY DISTRIBUTION CHANNEL

8.1. Overview By Distribution Channel
8.2. Historical and Forecast Data Analysis By Distribution Channel
8.3. Veterinary Hospitals Historic and Forecast Sales By Regions
8.4. Veterinary Clinics Historic and Forecast Sales By Regions
8.5. Retail Pharmacies Historic and Forecast Sales By Regions

9. GLOBAL COMPANION ANIMAL MEDICINE MARKET ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook
9.2. Introduction
9.3. North America Sales Analysis
- 9.3.1 Overview, Historic and Forecast Data Sales Analysis
- 9.3.2 North America By Segment Sales Analysis
- 9.3.3 North America By Country Sales Analysis
- 9.3.4 United States Sales Analysis
- 9.3.5 Canada Sales Analysis
- 9.3.6 Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1 Overview, Historic and Forecast Data Sales Analysis
- 9.4.2 Europe By Segment Sales Analysis
- 9.4.3 Europe By Country Sales Analysis
- 9.4.4 United Kingdom Sales Analysis
- 9.4.5 France Sales Analysis
- 9.4.6 Germany Sales Analysis
- 9.4.7 Italy Sales Analysis
- 9.4.8 Russia Sales Analysis
- 9.4.9 Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1 Overview, Historic and Forecast Data Sales Analysis
- 9.5.2 Asia Pacific By Segment Sales Analysis
- 9.5.3 Asia Pacific By Country Sales Analysis
- 9.5.4 China Sales Analysis
- 9.5.5 India Sales Analysis
- 9.5.6 Japan Sales Analysis
- 9.5.7 South Korea Sales Analysis
- 9.5.8 Australia Sales Analysis
- 9.5.9 South East Asia Sales Analysis
- 9.5.10 Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1 Overview, Historic and Forecast Data Sales Analysis
- 9.6.2 Latin America By Segment Sales Analysis
- 9.6.3 Latin America By Country Sales Analysis
- 9.6.4 Brazil Sales Analysis
- 9.6.5 Argentina Sales Analysis
- 9.6.6 Peru Sales Analysis
- 9.6.7 Chile Sales Analysis
- 9.6.8 Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1 Overview, Historic and Forecast Data Sales Analysis
- 9.7.2 Middle East & Africa By Segment Sales Analysis
- 9.7.3 Middle East & Africa By Country Sales Analysis
- 9.7.4 Saudi Arabia Sales Analysis
- 9.7.5 UAE Sales Analysis
- 9.7.6 Israel Sales Analysis
- 9.7.7 South Africa Sales Analysis
- 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE COMPANION ANIMAL MEDICINE COMPANIES

10.1. Companion Animal Medicine Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11. COMPANY PROFILES OF COMPANION ANIMAL MEDICINE INDUSTRY

11.1. Top Companies Market Share Analysis
11.2. Market Concentration Rate
11.3. Zoetis
- 11.3.1 Company Overview
- 11.3.2 Company Revenue
- 11.3.3 Products
- 11.3.4 Recent Developments
11.4. Merck Animal Health
- 11.4.1 Company Overview
- 11.4.2 Company Revenue
- 11.4.3 Products
- 11.4.4 Recent Developments
11.5. Boehringer Ingelheim Animal Health
- 11.5.1 Company Overview
- 11.5.2 Company Revenue
- 11.5.3 Products
- 11.5.4 Recent Developments
11.6. Elanco Animal Health
- 11.6.1 Company Overview
- 11.6.2 Company Revenue
- 11.6.3 Products
- 11.6.4 Recent Developments
11.7. Ceva SantA(C) Animale
- 11.7.1 Company Overview
- 11.7.2 Company Revenue
- 11.7.3 Products
- 11.7.4 Recent Developments
11.8. Virbac
- 11.8.1 Company Overview
- 11.8.2 Company Revenue
- 11.8.3 Products
- 11.8.4 Recent Developments
11.9. Dechra Pharmaceuticals
- 11.9.1 Company Overview
- 11.9.2 Company Revenue
- 11.9.3 Products
- 11.9.4 Recent Developments
11.10. Vetoquinol
- 11.10.1 Company Overview
- 11.10.2 Company Revenue
- 11.10.3 Products
- 11.10.4 Recent Developments
11.11. Neogen Corporation
- 11.11.1 Company Overview
- 11.11.2 Company Revenue
- 11.11.3 Products
- 11.11.4 Recent Developments
11.12. Orion Group
- 11.12.1 Company Overview
- 11.12.2 Company Revenue
- 11.12.3 Products
- 11.12.4 Recent Developments
11.13. Norbrook Holdings
- 11.13.1 Company Overview
- 11.13.2 Company Revenue
- 11.13.3 Products
- 11.13.4 Recent Developments
11.14. Chanelle Pharma
- 11.14.1 Company Overview
- 11.14.2 Company Revenue
- 11.14.3 Products
- 11.14.4 Recent Developments
11.15. HIPRA
- 11.15.1 Company Overview
- 11.15.2 Company Revenue
- 11.15.3 Products
- 11.15.4 Recent Developments
11.16. Kyoritsu Seiyaku
- 11.16.1 Company Overview
- 11.16.2 Company Revenue
- 11.16.3 Products
- 11.16.4 Recent Developments
11.17. BiogA(C)NA(C)Sis BagA3
- 11.17.1 Company Overview
- 11.17.2 Company Revenue
- 11.17.3 Products
- 11.17.4 Recent Developments